1. Is papillary thyroid microcarcinoma a biologically different disease? A propensity score‐matched analysis
   Yi‐Chiung Hsu et al, 2019, Journal of Surgical Oncology CrossRef
2. Molecular biology of papillary thyroid microcarcinomas: What is new?
   Bárbara Castro et al, 2016, Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo CrossRef
3. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin
   H. J. Hugo et al, 2017, Breast Cancer Research CrossRef
4. Role of P53, E-cadherin and BRAF as predictors of regional nodal recurrence for papillary thyroid cancer
   Khadiga M. Ali et al, 2019, Annals of Diagnostic Pathology CrossRef
5. Osteopontin Expression in Thyroid Cancer: Deciphering EMT-Related Molecular Mechanisms
   Bruna Prunes Pena Baroni Viana et al, 2021, Biomedicines CrossRef
6. Clinical significance of epithelial–mesenchymal transition-related markers expression in the micrometastatic sentinel lymph node of NSCLC
   A. Lafuente-Sanchis et al, 2020, Clinical and Translational Oncology CrossRef
7. HtrA1 regulates epithelial–mesenchymal transition in hepatocellular carcinoma
   Feng Zhu et al, 2015, Biochemical and Biophysical Research Communications CrossRef
8. Evaluating the role of hsa-miR-200c in reversing the epithelial to mesenchymal transition in prostate cancer
   Sanmitra Basu et al, 2020, Gene CrossRef
9. The significance and the predictive factors of microscopic lymph node metastasis in patients with clinically node negative papillary thyroid cancer: A retrospective cohort study
   Satoru Noda et al, 2015, International Journal of Surgery CrossRef
10. E-cadherin expression is associated with susceptibility and clinicopathological characteristics of thyroid cancer
    Changlin Zhou et al, 2019, Medicine CrossRef